Alliance Global Partners Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)
Alliance Global Partners analyst Aaron Grey maintained a Buy rating on OrganiGram Holdings today and set a price target of C$4.00.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Grey is an analyst with an average return of -4.8% and a 33.11% success rate. Grey covers the Healthcare sector, focusing on stocks such as OrganiGram Holdings, Canopy Growth, and Tilray.
In addition to Alliance Global Partners, OrganiGram Holdings also received a Buy from ATB Capital Markets’s Frederico Gomes in a report issued on February 11. However, on February 16, TipRanks – DeepSeek reiterated a Hold rating on OrganiGram Holdings (NASDAQ: OGI).
Based on OrganiGram Holdings’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of C$63.54 million and a net profit of C$19.97 million. In comparison, last year the company earned a revenue of C$42.73 million and had a GAAP net loss of C$22.96 million
Based on the recent corporate insider activity of 84 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OGI in relation to earlier this year.
Read More on OGI:
Disclaimer & DisclosureReport an Issue
- Organigram to Acquire Germany’s Sanity Group in Major European Cannabis Push
- Organigram to acquire remaining shares of Sanity Group for EUR113.4M
- Organigram Delivers Strong Q1 2026 Growth and Expands U.S. Reach
- Organigram reports Q1 revenue $97.3M, consensus $73.15M
- Organigram Sets February 10 Date to Release Q1 2026 Results
